$AVTX

$6.75 -$0.02 (0.3%) Close

$AVTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 53.6M shares outstanding

Who owns AVTX?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 60.2%

FMR LLC 9.5% · BlackRock, Inc. 8.1%

Institutional ownership

100.0%

+42.0 pts vs last qtr

Institutional holders

124

+27 vs last qtr

Net shares bought

+39.6M

by institutions in Q2 2026

New / sold out

54 / 27

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +4.0M
Deep Track Capital, LP NEW +3.6M

Biggest sellers in Q2 2026

T. Rowe Price Investment Management, Inc. SOLD OUT −2.2M
Millennium Management LLC SOLD OUT −835.5K

Who is planning to sell?

Notices of proposed sale, last 12 months

$8.57M

16 notices from 7 people

Shares covered

500.9K

0.93% of the company

Arranged in advance

84%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Mittie Doyle Officer 10b5-1 $2.63M
Christopher Ryan Sullivan Officer $2.08M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+3319.4%

+224.58% a year

Each share's claim on the business

−97.1%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $30.5M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years36% Under 1 year64%

Quarterly turnover

89.4%

of institutional shares changed hands

Top 10 managers, median time held

3 quarters

Super Investors

Investment managers reporting AVTX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
F FMR LLC	5.1M	9.51%	+2.2M (+77.1%)	Q4 '25	0.0%
Shares held by quarter Peak holding5.1M (Q2'26) Change over 8 quarters+5.1M Share of the company9.510% FMR LLC's full portfolio →
B BlackRock, Inc.	4.4M	8.14%	+4.0M (+1234.7%)	2023	0.0%
Shares held by quarter Peak holding4.4M (Q2'26) Change over 8 quarters+4.4M Share of the company8.140% BlackRock, Inc.'s full portfolio →

FMR LLC

5.1M

% of company

9.51%

Change vs last qtr

+2.2M (+77.1%)

Held since

Q4 '25

BlackRock, Inc.

4.4M

% of company

8.14%

Change vs last qtr

+4.0M (+1234.7%)

Held since

2023

28 more super investors behind a free account

See every manager holding Avalo Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting AVTX on Form N-PORT; together they hold 30.4% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$37.5M	2.0M	3.78%	0.35%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$31M	1.7M	3.12%	0.00%	June 30, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$37.5M

% of company

3.78%

% of the fund

0.35%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$31M

% of company

3.12%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Avalo Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
NG Neil Garry Arthur Insider	190.3K	0.35%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.350% Neil Garry Arthur's insider activity →
DM Doyle Mittie Insider	51.8K	0.10%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.100% Doyle Mittie's insider activity →

Neil Garry Arthur

Insider

190.3K

% of company

0.35%

Change vs last qtr

—

Held since

—

Doyle Mittie

Insider

51.8K

% of company

0.10%

Change vs last qtr

—

Held since

—

9 more holders behind a free account

See every insider and 5%+ holder of Avalo Therapeutics, Inc..

Comments